Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

C20orf29 Inhibitors

The chemical class known as C20ORF29 Inhibitors comprises a diverse array of compounds that are capable of influencing the function of the C20ORF29 protein by targeting various cellular pathways and processes integral to vesicular transport and endosomal-lysosomal trafficking. While these inhibitors do not engage directly with C20ORF29, their mode of action entails modifying the cellular environment or the functionality of other proteins and processes crucial for C20ORF29's operation. This strategy stems from the recognition that C20ORF29's activity and efficiency are intricately linked to a complex network of intracellular pathways, especially those involved in vesicle formation, transport, and the sorting of transmembrane proteins to lysosomes and endosomes.

In this class, some compounds are known to disrupt lysosomal acidification, a vital process for protein sorting in these organelles, which could possibly inhibit C20ORF29. Others may interfere with endocytic pathways by altering endosomal pH, impacting endosomal sorting and trafficking processes that could possibly inhibit C20ORF29. Moreover, the class includes compounds that target cytoskeletal components and dynamics crucial for vesicle movement within cells. By disrupting actin filaments or microtubules, these inhibitors impede vesicular transport, which could possibly inhibit the role of C20ORF29 in this process. Additionally, some inhibitors focus on altering functions of the Golgi apparatus, another key player in vesicular transport, thus influencing the overall process involving C20ORF29. Overall, the action of C20ORF29 Inhibitors is marked by their potential to modulate various cellular processes that are connected to the functionality of C20ORF29. By targeting these pathways, these compounds could possibly inhibit C20ORF29 by altering the conditions necessary for its optimal performance, leading to changes in its activity within the cell. This approach underlines the complexity and interconnectivity of cellular pathways and underscores the potential of influencing specific proteins by targeting related processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bafilomycin A1

88899-55-2sc-201550
sc-201550A
sc-201550B
sc-201550C
100 µg
1 mg
5 mg
10 mg
$98.00
$255.00
$765.00
$1457.00
280
(6)

Could possibly inhibit C20orf29 by affecting endosomal acidification, impacting its role in endosomal-lysosomal transport.

Monensin A

17090-79-8sc-362032
sc-362032A
5 mg
25 mg
$155.00
$525.00
(1)

Could possibly inhibit C20orf29 by disrupting endosomal transport, influencing its role in endosomal-lysosomal pathways.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Could possibly inhibit C20orf29 in vesicular trafficking pathways as a PI3K inhibitor.

Dynamin Inhibitor I, Dynasore

304448-55-3sc-202592
10 mg
$89.00
44
(2)

Could possibly inhibit C20orf29 by impacting endocytic trafficking relevant to its function through dynamin inhibition.

YM201636

371942-69-7sc-204193
5 mg
$217.00
6
(1)

Could possibly inhibit C20orf29 by influencing endosomal sorting and trafficking as a PIKfyve inhibitor.

Vinblastine

865-21-4sc-491749
sc-491749A
sc-491749B
sc-491749C
sc-491749D
10 mg
50 mg
100 mg
500 mg
1 g
$102.00
$235.00
$459.00
$1749.00
$2958.00
4
(0)

Could possibly inhibit C20orf29 by affecting vesicular transport pathways through microtubule dynamics disruption.

Nocodazole

31430-18-9sc-3518B
sc-3518
sc-3518C
sc-3518A
5 mg
10 mg
25 mg
50 mg
$59.00
$85.00
$143.00
$247.00
38
(2)

Could possibly inhibit C20orf29 by impacting transport processes associated with microtubule depolymerization.

Cytochalasin D

22144-77-0sc-201442
sc-201442A
1 mg
5 mg
$165.00
$486.00
64
(4)

Could possibly inhibit C20orf29 in actin-dependent trafficking processes by inhibiting actin polymerization.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

Could possibly inhibit C20orf29 in trafficking processes as a tyrosine kinase inhibitor.

FCM Lysing solution (1x)

sc-3621
150 ml
$62.00
8
(1)

Could possibly inhibit C20orf29 by raising lysosomal pH, affecting its role in lysosomal trafficking.